{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:42:13Z","timestamp":1791312133367,"version":"4.3.1"},"reference-count":38,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.2967\/jnumed.111.090902","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T06:50:52Z","timestamp":1310799052000},"page":"1218-1226","source":"Crossref","is-referenced-by-count":97,"title":["Evaluation of a Calibrated <sup>18<\/sup>F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment"],"prefix":"10.2967","volume":"52","author":[{"given":"Karl","family":"Herholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Haense","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2011,7,15]]},"reference":[{"key":"2021051712020787000_52.8.1218.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318207b1b9"},{"key":"2021051712020787000_52.8.1218.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70087-5"},{"key":"2021051712020787000_52.8.1218.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3115"},{"key":"2021051712020787000_52.8.1218.4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420114"},{"key":"2021051712020787000_52.8.1218.5","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.136"},{"key":"2021051712020787000_52.8.1218.6","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-009-0040-y"},{"key":"2021051712020787000_52.8.1218.7","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530070043010"},{"key":"2021051712020787000_52.8.1218.8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.5.738"},{"key":"2021051712020787000_52.8.1218.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.07.002"},{"key":"2021051712020787000_52.8.1218.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.02.064"},{"key":"2021051712020787000_52.8.1218.11","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2002.1208"},{"key":"2021051712020787000_52.8.1218.12","doi-asserted-by":"publisher","DOI":"10.1159\/000241879"},{"key":"2021051712020787000_52.8.1218.13","doi-asserted-by":"publisher","DOI":"10.1080\/10543400701329513"},{"key":"2021051712020787000_52.8.1218.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e8e8b8"},{"key":"2021051712020787000_52.8.1218.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.07.011"},{"key":"2021051712020787000_52.8.1218.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnm.0000230078.25609.2b"},{"key":"2021051712020787000_52.8.1218.17","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1718"},{"key":"2021051712020787000_52.8.1218.18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600263"},{"key":"2021051712020787000_52.8.1218.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2003.07.002"},{"key":"2021051712020787000_52.8.1218.20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/jcbfm.1988.104","article-title":"Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography","volume":"8","author":"Heiss","year":"1988","journal-title":"J Cereb Blood Flow Metab."},{"key":"2021051712020787000_52.8.1218.21","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(92)90099-J"},{"key":"2021051712020787000_52.8.1218.22","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.5.721"},{"key":"2021051712020787000_52.8.1218.23","first-page":"88","article-title":"Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease: a neuropsychological, EEG, and PET investigation","volume":"5","author":"Heiss","year":"1994","journal-title":"Dementia."},{"key":"2021051712020787000_52.8.1218.24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajgp.11.2.169"},{"key":"2021051712020787000_52.8.1218.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-004-0204-1"},{"key":"2021051712020787000_52.8.1218.26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","article-title":"A multi-center randomized proof-of-concept clinical trial applying [18F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease","volume":"22","author":"Tzimopoulou","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"2021051712020787000_52.8.1218.27","doi-asserted-by":"publisher","DOI":"10.1097\/WNN.0b013e318190cf75"},{"key":"2021051712020787000_52.8.1218.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70677-9"},{"key":"2021051712020787000_52.8.1218.29","doi-asserted-by":"publisher","DOI":"10.1002\/pst.355"},{"key":"2021051712020787000_52.8.1218.30","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.09.91"},{"key":"2021051712020787000_52.8.1218.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm177"},{"key":"2021051712020787000_52.8.1218.32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WAD.0b013e3181d1b814","article-title":"Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease","volume":"24","author":"McEvoy","year":"2010","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"2021051712020787000_52.8.1218.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.03.006"},{"key":"2021051712020787000_52.8.1218.34","doi-asserted-by":"publisher","DOI":"10.1038\/nm1700"},{"key":"2021051712020787000_52.8.1218.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.04.007"},{"key":"2021051712020787000_52.8.1218.36","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl178"},{"key":"2021051712020787000_52.8.1218.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70043-0"},{"key":"2021051712020787000_52.8.1218.38","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000244749.20056.d4"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.111.090902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:34:46Z","timestamp":1621280086000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.111.090902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,15]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,1]]},"published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.2967\/jnumed.111.090902"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.111.090902","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,15]]}}}